ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag federal funding genetics genomics microbiology

Opinion: Hunting a Changing Virus
Libusha Kelly | Jul 1, 2021 | 3 min read
A broad and nimble sequencing program is necessary to track, anticipate, and quash SARS-CoV-2 and other dangerous pathogens that threaten humanity.
USDA Proposes Ambitious New Plant Genome Initiative
Christopher Anderson | Aug 6, 1989 | 4 min read
WASHINGTON-In an ambitious answer to the National Institutes of Health's Human Genome Project, the U.S. Department of Agriculture has sprouted plans for a parallel project to map the genetic structure of key food plants. The proposal, presented by USDA program manager Jerome Miksche at a meeting of the NIH genome project's advisory committee in June, would identify genetic traits that can increase yield and disease resistance. The price tag is estimated to be $500 million over 10 years. In recen
Privatizing the Human Genome?
Paul Smaglik | Jun 7, 1998 | 10 min read
Principals behind joint-venture proposal and public effort seek to define relationships A private effort to sequence the human genome four years ahead of the Human Genome Project's 2005 goal could either compete directly with the federal project or meld seamlessly with it. Before any relationship between the two efforts becomes formalized, scientists and federal officials involved with the Human Genome Project must determine whether the private approach will work, who will own the data, how qu
Researchers Blast Open Pathogen Genome
Barry Palevitz | Aug 18, 2002 | 6 min read
Image: Courtesy of Tim Elkins BRUTE FORCE: Remnant of an appressorium formed on Mylar. The appressorium produced a peg-like extension that penetrated the film, leaving a round hole. (Reprinted with permission, Annual Review of Microbiology, 50:491-512, 1996.) "The Lord shall smite thee with a consumption, and with a fever, and with an inflammation, and with an extreme burning, and with the sword, and with BLASTING, and with mildew; and they shall pursue thee until thou perish." Deuteronom
Sequencing Stakes: Celera Genomics Carves Its Niche
Ricki Lewis | Jul 18, 1999 | 8 min read
J. Craig Venter is no stranger to contradiction and controversy. He seems to thrive on it. In 1991, when the National Institutes of Health was haggling over patenting expressed sequence tags (ESTs)--a shortcut to identifying protein-encoding genes--Venter the inventor accepted a private offer to found The Institute for Genomic Research (TIGR) in Rockville, Md. TIGR would discover ESTs and give most of them to a commercial sibling, Human Genome Sciences (HGS), to market. ESTs are now a standard
Louise Slaughter, Scientist and Congresswoman, Dies
Kerry Grens | Mar 19, 2018 | 2 min read
Trained in microbiology, Slaughter championed science, women’s health, and consumer protections as a member of the US House of Representatives.
African American Genome Mappers Pledge To Carry On Despite Grant Rejection
Neeraja Sankaran | Mar 5, 1995 | 6 min read
Researchers working on a large-scale plan to develop a linkage map of the genome of African Americans a project similar to the Human Genome Project (HGP)_vow to continue their efforts, despite being rejected for funding by the National Institutes of Health. As they pursue other sources of funding, they say they will carry on with the project in a loosely associated alliance of smaller research efforts at Howard University and other institutions. "It is just too important a project to be dismant
Updated Sept 1
coronavirus pandemic news articles covid-19 sars-cov-2 virology research science
Follow the Coronavirus Outbreak
The Scientist | Feb 20, 2020 | 10+ min read
Saliva tests screen staff and students at University of Illinois; Study ranks species most susceptible to SARS-CoV-2 infection; COVID-19 clinical trials test drugs that inhibit kinin system
Bioterrorism Research: New Money, New Anxieties
John Dudley Miller | Apr 6, 2003 | 8 min read
Ned Shaw US scientists have reason to feel both heady and scared. The federal government recently released unprecedented billions of dollars to fund bioterrorism research. Yet, the merits of this sudden shift in focus are being debated, and some worry that the money will be squandered or wasted. "I have been really very upset by the focus on bioterrorism," says Stanley Falkow, professor of microbiology and immunology and of medicine at Stanford University. "Everybody's talking about it, but th
Alfred Pühler
Cormac Sheridan | Jan 12, 2009 | 3 min read
Alfred Pühler Forty years (and counting) at the forefront of microbiology research have not dimmed Pühler's infectious enthusiasm or voracious work ethic. By Cormac Sheridan Alfred Pühler has been a powerhouse in German microbiological research—initially in the area of plant-microbe interactions and later in industrial microbiology—over the past four decades. But he actually started out in nuclear physics, obtain

Run a Search

ADVERTISEMENT